Imunon, Inc. (LON:0HUZ)
London · Delayed Price · Currency is GBP · Price in USD 0.8801
-0.0506 (-5.44%)
Jan 29, 2025, 2:56 PM GMT
Imunon Market Cap
Imunon has a market cap or net worth of 8.16 million as of February 12, 2026. Its market cap has decreased by -23.38% in one year.
Market Cap
8.16M
Enterprise Value
5.12M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.88
Market Cap Chart
Since July 24, 1995, Imunon's market cap has increased from 7.19M to 8.16M, an increase of 13.48%. That is a compound annual growth rate of 0.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 8.52M | -11.45% |
| Dec 31, 2025 | 9.63M | -12.52% |
| Dec 31, 2024 | 11.00M | 119.29% |
| Dec 29, 2023 | 5.02M | -39.76% |
| Dec 30, 2022 | 8.33M | -75.87% |
| Dec 31, 2021 | 34.52M | 77.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sareum Holdings | 24.16M |
| Fusion Antibodies | 19.38M |
| Oxford BioDynamics | 11.80M |
| IXICO | 9.50M |
| Genflow Biosciences | 9.38M |
| OptiBiotix Health | 7.64M |
| Futura Medical | 7.57M |
| CRISM Therapeutics | 7.37M |